Sertraline‐induced exacerbation of Tics in Tourette's syndrome
Identifieur interne : 005829 ( Main/Exploration ); précédent : 005828; suivant : 005830Sertraline‐induced exacerbation of Tics in Tourette's syndrome
Auteurs : Robert A. Hauser [États-Unis] ; Theresa A. Zesiewicz [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1995-09.
English descriptors
- KwdEn :
- 1-Naphthylamine (administration & dosage), 1-Naphthylamine (adverse effects), 1-Naphthylamine (analogs & derivatives), 1-Naphthylamine (therapeutic use), Adolescent, Depressive Disorder (drug therapy), Depressive Disorder (psychology), Female, Humans, Serotonin Uptake Inhibitors (adverse effects), Serotonin Uptake Inhibitors (therapeutic use), Sertraline, Tic Disorders (complications), Tic Disorders (etiology), Tourette Syndrome (complications).
- MESH :
- chemical , administration & dosage : 1-Naphthylamine.
- chemical , adverse effects : 1-Naphthylamine, Serotonin Uptake Inhibitors.
- chemical , analogs & derivatives : 1-Naphthylamine.
- chemical , therapeutic use : 1-Naphthylamine, Serotonin Uptake Inhibitors.
- complications : Tic Disorders, Tourette Syndrome.
- drug therapy : Depressive Disorder.
- etiology : Tic Disorders.
- psychology : Depressive Disorder.
- Adolescent, Female, Humans, Sertraline.
Url:
DOI: 10.1002/mds.870100529
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003C44
- to stream Istex, to step Curation: 003C44
- to stream Istex, to step Checkpoint: 003C60
- to stream PubMed, to step Corpus: 004916
- to stream PubMed, to step Curation: 004916
- to stream PubMed, to step Checkpoint: 004924
- to stream Ncbi, to step Merge: 004A67
- to stream Ncbi, to step Curation: 004A67
- to stream Ncbi, to step Checkpoint: 004A67
- to stream Main, to step Merge: 008991
- to stream Main, to step Curation: 005829
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sertraline‐induced exacerbation of Tics in Tourette's syndrome</title>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</author>
<author><name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:976B051CEA139B231737922D9AAB56632C4CD5E9</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1002/mds.870100529</idno>
<idno type="url">https://api.istex.fr/document/976B051CEA139B231737922D9AAB56632C4CD5E9/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003C44</idno>
<idno type="wicri:Area/Istex/Curation">003C44</idno>
<idno type="wicri:Area/Istex/Checkpoint">003C60</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Hauser R:sertraline:induced:exacerbation</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8552129</idno>
<idno type="wicri:Area/PubMed/Corpus">004916</idno>
<idno type="wicri:Area/PubMed/Curation">004916</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004924</idno>
<idno type="wicri:Area/Ncbi/Merge">004A67</idno>
<idno type="wicri:Area/Ncbi/Curation">004A67</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004A67</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Hauser R:sertraline:induced:exacerbation</idno>
<idno type="wicri:Area/Main/Merge">008991</idno>
<idno type="wicri:Area/Main/Curation">005829</idno>
<idno type="wicri:Area/Main/Exploration">005829</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Sertraline‐induced exacerbation of Tics in Tourette's syndrome</title>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1995-09">1995-09</date>
<biblScope unit="vol">10</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="682">682</biblScope>
<biblScope unit="page" to="684">684</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">976B051CEA139B231737922D9AAB56632C4CD5E9</idno>
<idno type="DOI">10.1002/mds.870100529</idno>
<idno type="ArticleID">MDS870100529</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>1-Naphthylamine (administration & dosage)</term>
<term>1-Naphthylamine (adverse effects)</term>
<term>1-Naphthylamine (analogs & derivatives)</term>
<term>1-Naphthylamine (therapeutic use)</term>
<term>Adolescent</term>
<term>Depressive Disorder (drug therapy)</term>
<term>Depressive Disorder (psychology)</term>
<term>Female</term>
<term>Humans</term>
<term>Serotonin Uptake Inhibitors (adverse effects)</term>
<term>Serotonin Uptake Inhibitors (therapeutic use)</term>
<term>Sertraline</term>
<term>Tic Disorders (complications)</term>
<term>Tic Disorders (etiology)</term>
<term>Tourette Syndrome (complications)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>1-Naphthylamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>1-Naphthylamine</term>
<term>Serotonin Uptake Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>1-Naphthylamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>1-Naphthylamine</term>
<term>Serotonin Uptake Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Tic Disorders</term>
<term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Depressive Disorder</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Tic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Depressive Disorder</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Female</term>
<term>Humans</term>
<term>Sertraline</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Floride</li>
</region>
<settlement><li>Tampa</li>
</settlement>
<orgName><li>Université de Floride du Sud</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Floride"><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</region>
<name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005829 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005829 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:976B051CEA139B231737922D9AAB56632C4CD5E9 |texte= Sertraline‐induced exacerbation of Tics in Tourette's syndrome }}
This area was generated with Dilib version V0.6.23. |